您的当前位置:首页 > 行业数据 > 表6:主要GLP-1类减重药物中国市场情况(截至2025年)
图片属性
图片格式:PNG 图片大小:155KB 图片尺寸:3555*1160
同报告图片
 / 4
表6:主要GLP-1类减重药物中国市场情况(截至2025年)_第1页
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
表6:主要GLP-1类减重药物中国市场情况(截至2025年)_第2页
表6:主要GLP-1类减重药物中国市场情况(截至2025年)_第3页
表6:主要GLP-1类减重药物中国市场情况(截至2025年)_第4页
表6:主要GLP-1类减重药物中国市场情况(截至2025年)_第5页
所属报告: 三个皮匠报告:2026中国体重管理市场洞察报告.pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠